These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 11283029)

  • 21. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease.
    Kimura H; Ito Y; Suzuki R; Nishiyama Y
    Rev Med Virol; 2008; 18(5):305-19. PubMed ID: 18494041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
    Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
    J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
    Gotoh K; Ito Y; Ohta R; Iwata S; Nishiyama Y; Nakamura T; Kaneko K; Kiuchi T; Ando H; Kimura H
    J Infect Dis; 2010 Aug; 202(3):461-9. PubMed ID: 20560768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells.
    Wagner HJ; Jabs W; Smets F; Wessel M; Fischer L; Offner G; Kirchner H; Bucsky P
    Klin Padiatr; 2000; 212(4):206-10. PubMed ID: 10994552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.
    Stevens SJ; Verschuuren EA; Pronk I; van Der Bij W; Harmsen MC; The TH; Meijer CJ; van Den Brule AJ; Middeldorp JM
    Blood; 2001 Mar; 97(5):1165-71. PubMed ID: 11222357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.
    Martelius T; Lappalainen M; Aalto SM; Nihtinen A; Hedman K; Anttila VJ
    Clin Microbiol Infect; 2010 Jun; 16(6):657-62. PubMed ID: 19694766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
    Yancoski J; Danielian S; Ibañez J; Turconi A; Cuarterolo M; Zelazko M; Niesters Hubert GM
    J Clin Virol; 2004 Sep; 31(1):58-65. PubMed ID: 15288615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
    Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
    J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative tissue polymerase chain reaction for Epstein-Barr virus in pediatric solid organ recipients.
    Gupta M; Filler G; Kovesi T; Shaw L; Forget C; Carpenter B; Reisman J; Feber J; Diaz-Mitoma F
    Am J Kidney Dis; 2003 Jan; 41(1):212-9. PubMed ID: 12500239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
    Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
    J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment.
    Bauer CC; Jaksch P; Aberle SW; Haber H; Lang G; Klepetko W; Hofmann H; Puchhammer-Stöckl E
    J Clin Microbiol; 2007 Feb; 45(2):324-8. PubMed ID: 17151208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma.
    Perandin F; Cariani E; Pollara CP; Manca N
    BMC Microbiol; 2007 Mar; 7():22. PubMed ID: 17391518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
    Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
    J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection.
    Friis AM; Akerlund B; Gyllensten K; Aleman A; Bratt G; Sandström E; Ernberg I
    Vaccine; 2012 Sep; 30(42):6093-8. PubMed ID: 22863659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.
    Zawilinska B; Kosinska A; Lenart M; Kopec J; Piatkowska-Jakubas B; Skotnicki A; Kosz-Vnenchak M
    Acta Biochim Pol; 2008; 55(4):693-9. PubMed ID: 19015775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.